Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [911]
News [3678]
Articles [22]
Editorials [1]
Conferences [135]
elearning [0]
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and...
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
19 Jun 2014
Advances in chronic lymphocytic leukaemia: Expert panel discussion
Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan
Advances in chronic lymphocytic leukaemia: Expert panel discussion ( Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan )
19 Jun 2014
Genetically modified T cells fight haematological cancer
Dr Roman Galetto - Cellectis Therapeutics, Paris, France
Genetically modified T cells fight haematological cancer ( Dr Roman Galetto - Cellectis Therapeutics, Paris, France )
19 Jun 2014
Investigating anticarcinogenic compounds as an alternative to chemo
Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy
Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )
6 Jun 2014
WIN Symposium 2014: Breakthrough biomarker investigations and combination...
Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg
WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies ( Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg )
6 May 2014
Work and history of the Kidney Cancer Association
Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer...
Work and history of the Kidney Cancer Association ( Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA )
6 May 2014
Intratumour heterogeneity in renal and lung cancer
Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK
Intratumour heterogeneity in renal and lung cancer ( Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK )
6 May 2014
High levels of mutated p53 indicate metastatic phenotype
Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center...
High levels of mutated p53 indicate metastatic phenotype ( Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA )
5 May 2014
Impact of the liver environment upon the efficacy of induction therapy
Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France
Impact of the liver environment upon the efficacy of induction therapy ( Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France )
1 May 2014
Study identifies new strategy to overcome breast cancer resistance to HER2...
Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA
Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies ( Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA )
1 May 2014
Role of genomics in assessing risk, especially in ovarian cancer
Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA
Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )
1 May 2014
Targeted Anti-cancer Therapies (TAT) conference roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Targeted Anti-cancer Therapies (TAT) conference roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Apr 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation